Parkinson's Disease




12 weeks

Parkinson’s Disease with Dementia

Official Title

Parkinson's Disease with Dementia

Study Summary

A randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of study drug LY3154207 in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 40-85 years old
Inclusion Diagnosis of Parkinson's Disease of at least 2 years and have been experiencing memory loss.
Exclusion Have significant central nervous system disease, other than PD, that may affect cognition or the ability to complete the study, including but not limited to, other dementias (e.g., Alzheimer's disease).
Start Date
Compensation $600
Location Orlando, FL

Study Information

Condition Parkinson's Disease
Study Phase Phase 2a

Administrative Information

Investigators Ira Goodman, MD

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.